S. Shamblin

Bruno C. Hancock, G. Zografi, S. Shamblin, 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Advance Understanding of Buffer Behavior during Lyophilization

E. Shalaev, Dushyant B. Varshney, S. Shamblin, 2015 .

The effects of co-lyophilized polymeric additives on the glass transition temperature and crystallization of amorphous sucrose

G. Zografi, S. Shamblin, Eva Y. Huang, 1996 .

Interpretation of relaxation time constants for amorphous pharmaceutical systems.

Bruno C. Hancock, B C Hancock, M. Pikal, 2000, Journal of pharmaceutical sciences.

Molecular mobility of amorphous pharmaceuticals determined using differential scanning calorimetry

Bruno C. Hancock, S. Shamblin, 2001 .

Phase Behavior of Drug-Lipid-Surfactant Ternary Systems toward Understanding the Annealing-Induced Change.

K. Zangger, P. Laggner, A. Paudel, 2021, Molecular pharmaceutics.

Evolution of the microstructure and the drug release upon annealing the drug loaded lipid-surfactant microspheres.

I. Ardelean, P. Laggner, A. Paudel, 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Polymeric Nanoparticles for Increased Oral Bioavailability and Rapid Absorption Using Celecoxib as a Model of a Low-Solubility, High-Permeability Drug

M. Morgen, R. Steenwyk, A. Bello, 2011, Pharmaceutical Research.

Mixing behavior of colyophilized binary systems.

G. Zografi, L. S. Taylor, S. Shamblin, 1998, Journal of pharmaceutical sciences.

Enthalpy Relaxation in Binary Amorphous Mixtures Containing Sucrose

G. Zografi, S. Shamblin, 1998, Pharmaceutical Research.

Improved Protocol and Data Analysis for Accelerated Shelf-Life Estimation of Solid Dosage Forms

Patrick Lukulay, Anthony J. Carella, B. Macdonald, 2007, Pharmaceutical Research.

Impact of sertraline salt form on the oxidative stability in powder blends.

Weili Yu, L. S. Taylor, Kenneth C. Waterman, 2014, International journal of pharmaceutics.

A Pragmatic Test of a Simple Calorimetric Method for Determining the Fragility of Some Amorphous Pharmaceutical Materials

Bruno C. Hancock, Michael J. Pikal, M. Pikal, 1998, Pharmaceutical Research.

Polyamorphism: a pharmaceutical science perspective

Bruno C. Hancock, E. Shalaev, S. Shamblin, 2002, The Journal of pharmacy and pharmacology.

Amorphous Pharmaceutical Systems

Bruno C. Hancock, S. Luthra, S. Shamblin, 2013 .

Correction to Discovery of the Hemifumarate and (α-l-Alanyloxy)methyl Ether as Prodrugs of an Antirheumatic Oxindole: Prodrugs for the Enolic OH Group.

R. Robinson, E. F. Fiese, T. Liston, 1996, Journal of Medicinal Chemistry.

Pharmacoscintigraphy studies to assess the feasibility of a controlled release formulation of ziprasidone.

I. Wilding, A. Connor, A. Thombre, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Effect of excipient properties, water activity, and water content on the disproportionation of a pharmaceutical salt

K. Arora, Mitulkumar A. Patel, L. S. Taylor, 2018, International journal of pharmaceutics.

Controlled Release Using Bilayer Osmotic Tablet Technology: Reducing Theory to Practice

S. Shamblin, 2010 .

Polymeric Nanoparticles for Increased Oral Bioavailability and Rapid Absorption Using Celecoxib as a Model of a Low-Solubility, High-Permeability Drug

M. Morgen, R. Steenwyk, A. Bello, 2011, Pharmaceutical Research.

Estimating the Critical Molecular Mobility Temperature (TK) of Amorphous Pharmaceuticals

Bruno C. Hancock, S. Shamblin, K. Christensen, 1998, Pharmaceutical Research.

Assessing the Risk of Salt Disproportionation Using Crystal Structure and Surface Topography Analysis

K. Arora, Mitulkumar A. Patel, S. Luthra, 2018, Crystal Growth & Design.